Manages manifestations of psychotic disorders. ANDA 84113, held by Upsher Smith Labs. Chlorpromazine Hydrochloride.
As of Nov 16, 2026, ANDA 84113 (Chlorpromazine Hydrochloride), held by Upsher Smith Labs, was first approved by FDA on Jul 9, 1974, with 28 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE For the management of manifestations of psychotic disorders. For the treatment of schizophrenia. To control nausea and vomiting. For relief of restlessness and apprehension before surgery. For acute intermittent porphyria. As an adjunct in the treatment of tetanus. To control the manifestations of the manic type of manic-depressive illness. For relief of intractable hiccups.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 9, 1974 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Chlorpromazine Hydrochloride50MG · tablet;oral | Chlorpromazine Hydrochloride | RxReference drug |
| Feb 5, 2020 | Supplement 122Labeling · Standard review | Approved | None posted |
| Feb 23, 2017 | Supplement 119Labeling · Standard review | Approved | None posted |
| Aug 29, 2016 | Supplement 118Manufacturing | Approved | None posted |
| Sep 13, 2011 | Supplement 114Labeling | Approved | None posted |
| Dec 3, 2010 | Supplement 111Labeling | Approved | None posted |
| Aug 24, 2009 | Supplement 108Labeling | Approved | None posted |
| Nov 19, 2008 | Supplement 105Labeling | Approved | None posted |
| Nov 25, 2002 | Supplement 90Labeling | Approved | None posted |
| Mar 22, 1999 | Supplement 89Labeling | Approved | None posted |
| Mar 22, 1999 | Supplement 88Manufacturing | Approved | None posted |
| Feb 5, 1996 | Supplement 87Manufacturing | Approved | None posted |
| Sep 16, 1992 | Supplement 86Labeling | Approved | None posted |
| Dec 31, 1991 | Supplement 85Labeling | Approved | None posted |
| Nov 29, 1990 | Supplement 84Labeling | Approved | None posted |
| Feb 14, 1989 | Supplement 83Manufacturing | Approved | None posted |
| Jul 8, 1988 | Supplement 81Manufacturing | Approved | None posted |
| Apr 26, 1988 | Supplement 82Labeling | Approved | None posted |
| Apr 14, 1988 | Supplement 79Manufacturing | Approved | None posted |
| Mar 8, 1988 | Supplement 80Labeling | Approved | None posted |
| Dec 7, 1987 | Supplement 76Manufacturing | Approved | None posted |
| Dec 7, 1987 | Supplement 75Manufacturing | Approved | None posted |
| Mar 12, 1987 | Supplement 74Manufacturing | Approved | None posted |
| Jul 10, 1986 | Supplement 73Manufacturing | Approved | None posted |
| Jul 10, 1986 | Supplement 72Manufacturing | Approved | None posted |
| Mar 11, 1986 | Supplement 70Manufacturing | Approved | None posted |
| Feb 1, 1985 | Supplement 69Manufacturing | Approved | None posted |
| Apr 10, 1984 | Supplement 65Manufacturing | Approved | None posted |
| Apr 26, 1982 | Supplement 63Manufacturing | Approved | None posted |
| Jul 9, 1974 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters